Research Article

Allomaltol derivatives as Antimycobacterial agents: In vitro and in silico evaluations with potential protein targets

Volume: 54 Number: 3 December 30, 2024
EN

Allomaltol derivatives as Antimycobacterial agents: In vitro and in silico evaluations with potential protein targets

Abstract

Background and Aims: Mycobacterium species cause life-threatening pulmonary and extrapulmonary diseases in humans. This study aimed to evaluate the potential antimycobacterial activity of allomaltol derivatives in the Mannich base structure in vitro and in silico. Methods: The antimycobacterial activity of each compound against Mycobacterium tuberculosis and Mycobacterium avium was tested using a resazurin microplate assay, and cytotoxicity was assessed using human MRC-5 and He-La cells. Using the SwissTarget tool, Rip1 protease, the metallo-beta-lactamase (MBL) superfamily protein, the serine protease Rv3671c, and zinc metalloprotease 1 (ZMP1) were identified as potential targets. Blind docking was performed for compound 14 using CB-Dock to identify and assess the most probable binding sites on the target proteins. Defined docking was performed with Flare to determine the best binding pose at the predicted binding pocket. The druglikeness of hit compounds, including the partition coefficient, number of hydrogen bond donors/acceptors, molecular refractivity, topological polar surface area (PSA), and gastrointestinal and blood-brain barrier absorption, were evaluated using the SwissADME tool. Results: Compounds with methyl-substituted piperidine groups were found to have antimycobacterial activity (MICs: 2 μg/mL) against M. avium, which was as potent as the clinically used drugs ethambutol and streptomycin. The predicted physicochemical properties of the four hit compounds were satisfactory. According to the docking results, the binding energies of compound 14, which showed the best overall antimycobacterial activity, ranged from -8.14 to -5.97 kcal/mol, with ZMP1 showing the lowest binding energy. Conclusion: The results of this study provide evidence that allomaltol derivatives are promising antimycobacterial agents with satisfactory drug profiles.

Keywords

References

  1. Abdullahi, M., Uzairu, A., Shallangwa, G. A., Arthur, D. E., Umar, B. A., & Ibrahim, M. T. (2020). Virtual molecular docking study of some novel carboxamide series as new anti-tubercular agents. European Journal of Chemistry, 11 (1), 30-36. https://doi.org/10. 5155/eurjchem.11.1.30-36.1955 google scholar
  2. Amiri, M. R. J., Siami, R., & Khaledi, A. (2018). Tuberculosis Sta-tus and Coinfection of Pulmonary Fungal Infections in Patients Referred to Reference Laboratory of Health Centers Ghaemshahr City during 2007-2017. Ethiopian Journal of Health Sciences, 28(6). https://doi.org/10.4314/ejhs.v28i6.2 google scholar
  3. Aytemir, M. D., & Çalış, Ü. (2007). Synthesis of Some Novel Mannich Bases Derived From Allomaltol and Evaluation of Their Anticon-vulsant Activities. Hacettepe University Journal of the Faculty of Pharmacy 27(1), 1-10. google scholar
  4. Aytemir, M.D. & Çalış, Ü. (2006). Synthesis of some new hydrox-ypyranone derivatives and evaluation of their anticonvulsant ac-tivities. FABAD Journal of Pharmaceutical Sciences 31, 23-29. google scholar
  5. Aytemir, M. D., Çaliş, Ü., & Özalp, M. (2004). Synthesis and Evaluation of Anticonvulsant and Antimicrobial Activities of 3-Hydroxy-6-methyl-2-substituted 4H-Pyran-4-one Derivatives. Archiv Der Pharmazie, 337(5), 281-288. https://doi.org/10.1002/ ardp.200200754 google scholar
  6. Aytemir, M. D., & Çalış, Ü. (2010). Anticonvulsant and Neuro-toxicity Evaluation of Some Novel Kojic Acids and Allomal-tol Derivatives. Archiv Der Pharmazie, 343(3), 173-181. https: //doi.org/10.1002/ardp.200900236 google scholar
  7. Aytemir, M. D., & Özçelik, B. (2011). Synthesis and biological ac-tivities of new Mannich bases of chlorokojic acid derivatives. Medicinal Chemistry Research, 20(4), 443-452. https://doi.org/ 10.1007/s00044-010-9338-x google scholar
  8. Aytemir, M. D., Özçelik, B., & Karakaya, G. (2013). Evaluation of bioactivities of chlorokojic acid derivatives against dermatophytes couplet with cytotoxicity. Bioorganic & Medicinal Chemistry Let-ters, 23(12), 3646-3649. https://doi.org/10.1016/j.bmcl.2013.03. 098 google scholar

Details

Primary Language

English

Subjects

Pharmacology and Pharmaceutical Sciences (Other)

Journal Section

Research Article

Publication Date

December 30, 2024

Submission Date

May 27, 2024

Acceptance Date

August 14, 2024

Published in Issue

Year 2024 Volume: 54 Number: 3

APA
Karakaya, G., Hamdoun, S., Oflaz, O., Özçelik, B., & Dilsiz Aytemir, M. (2024). Allomaltol derivatives as Antimycobacterial agents: In vitro and in silico evaluations with potential protein targets. İstanbul Journal of Pharmacy, 54(3), 446-455. https://doi.org/10.26650/IstanbulJPharm.2024.1488237
AMA
1.Karakaya G, Hamdoun S, Oflaz O, Özçelik B, Dilsiz Aytemir M. Allomaltol derivatives as Antimycobacterial agents: In vitro and in silico evaluations with potential protein targets. iujp. 2024;54(3):446-455. doi:10.26650/IstanbulJPharm.2024.1488237
Chicago
Karakaya, Gülşah, Sami Hamdoun, Ofcan Oflaz, Berrin Özçelik, and Mutlu Dilsiz Aytemir. 2024. “Allomaltol Derivatives As Antimycobacterial Agents: In Vitro and in Silico Evaluations With Potential Protein Targets”. İstanbul Journal of Pharmacy 54 (3): 446-55. https://doi.org/10.26650/IstanbulJPharm.2024.1488237.
EndNote
Karakaya G, Hamdoun S, Oflaz O, Özçelik B, Dilsiz Aytemir M (December 1, 2024) Allomaltol derivatives as Antimycobacterial agents: In vitro and in silico evaluations with potential protein targets. İstanbul Journal of Pharmacy 54 3 446–455.
IEEE
[1]G. Karakaya, S. Hamdoun, O. Oflaz, B. Özçelik, and M. Dilsiz Aytemir, “Allomaltol derivatives as Antimycobacterial agents: In vitro and in silico evaluations with potential protein targets”, iujp, vol. 54, no. 3, pp. 446–455, Dec. 2024, doi: 10.26650/IstanbulJPharm.2024.1488237.
ISNAD
Karakaya, Gülşah - Hamdoun, Sami - Oflaz, Ofcan - Özçelik, Berrin - Dilsiz Aytemir, Mutlu. “Allomaltol Derivatives As Antimycobacterial Agents: In Vitro and in Silico Evaluations With Potential Protein Targets”. İstanbul Journal of Pharmacy 54/3 (December 1, 2024): 446-455. https://doi.org/10.26650/IstanbulJPharm.2024.1488237.
JAMA
1.Karakaya G, Hamdoun S, Oflaz O, Özçelik B, Dilsiz Aytemir M. Allomaltol derivatives as Antimycobacterial agents: In vitro and in silico evaluations with potential protein targets. iujp. 2024;54:446–455.
MLA
Karakaya, Gülşah, et al. “Allomaltol Derivatives As Antimycobacterial Agents: In Vitro and in Silico Evaluations With Potential Protein Targets”. İstanbul Journal of Pharmacy, vol. 54, no. 3, Dec. 2024, pp. 446-55, doi:10.26650/IstanbulJPharm.2024.1488237.
Vancouver
1.Gülşah Karakaya, Sami Hamdoun, Ofcan Oflaz, Berrin Özçelik, Mutlu Dilsiz Aytemir. Allomaltol derivatives as Antimycobacterial agents: In vitro and in silico evaluations with potential protein targets. iujp. 2024 Dec. 1;54(3):446-55. doi:10.26650/IstanbulJPharm.2024.1488237